1991;28:681-5) describe their experience with four linked DNA markers (x227, Cl ip 1, YN5.48, and ECB27) flanking the familial adenomatous polyposis (FAP) locus. They conclude that "lod scores are sufficiently high to allow the use of these probes in presymptomatic diagnosis". In the absence of large bowel adenomas or extracolonic manifestations of the FAP gene, a Bayesian approach to risk assessment, incorporating age of onset and DNA data, may guide clinical screening policy. We have developed a computerised regional register for FAP (called 'MegaBASE/FAP') which facilitates both risk assessment and coordination of screening examinations for the extended families of index patients.
The core of the register software is the pedigree and this can be viewed on screen and printed out for use in the clinic. The main database contains information relating to administrative, screening, surgical, pathological, and genetic aspects of patient management, and this can be viewed and edited either on a text based screen or directly on the pedigree.
From the genotypes stored on each family member, input files for the LINKAGE' programs can be written automatically within the database, which also contains a built in age of onset curve specified as 20 liability classes. The time consuming and error prone manual creation of LINKAGE files is thereby avoided, making risk evaluation both simpler and more reliable.
Cachon For inclusion in these directories, a disease must be a well defined pathological entity, and the name for it should be simple, unambiguous, and descriptive. I am thankful that the use of numbers, initials, and eponyms are avoided where possible, although they are listed under synonyms. Older names for enzymes are also listed under synonyms and are indexed, so there is no difficulty about learning to use the correct name. There are brief notes on each disease and these are a model of precision and clarity.
The wide scope of this book is shown by its divisions into sections on inborn errors of metabolism (all genetic), disorders of steroid and endocrine metabolism, disorders of red cells and of haemoglobin, disorders of platelets and clotting, amyloidoses, collagenoses, muscular dystrophies, nutritional defects, diabetes mellitus with its syndromes, and endocrine tumours. There are also included some benign metabolic conditions so that they may be identified as 'non-diseases'.
The authors recognise that individual enzyme defects will be caused by different genes, and even by genes at different loci. Therefore they have chosen the enzyme defect as a basis for naming most of the diseases in this book. This is of great practical value. Only in the amyloidoses are DNA mutations included in the definition. It seems a good idea to use DNA mutations rarely, since they are being recognised at such a rate that disease names which incorporate them will have to be modified and expanded in the near future. It is helpful to a non-biochemist to have the biochemical basis of disease so clearly and correctly described in this handbook. As an example of how the editors are obsessed with correctness, the reader is even shown how to write glucose 6-phosphate and glucose-6-phosphatase. 
